Pre-market
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • ✓200 free stock & ETF trades
  • ✓Unlimited commission-free trades on 180+ select ETFs
  • ✓Offer ends September 30, 2026
Stocks/TSX-V/MIR

MedMira Inc (MIR : TSX-V)

Common Stock

$0.07

CAD

+0.00 (%)

Last updated: 2026-09-28

Follow MIR

MIR

MedMira Inc

Source:WealthAwesomeWealthAwesome
↑ $0.01 (16.67%)
30 day period
$0.06$0.07$0.07Aug 4Sep 2Sep 28

Performance

1 Day

+0.00%

1 Week

+7.69%

1 Month

+0.00%

YTD

+7.69%

Key Statistics

Market Cap

$49.12M

52W High

$0.11

52W Low

$0.05

P/E Ratio

-

50 Day MA

$0.07

200 Day MA

$0.07

Beta

0.80

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/28/2026$0.07$0.07$0.07$0.07$0.0720,100
9/25/2026$0.06$0.07$0.06$0.07$0.07183,335
9/23/2026$0.07$0.07$0.07$0.07$0.071,000
9/22/2026$0.07$0.07$0.07$0.07$0.0740,000
9/21/2026$0.07$0.07$0.07$0.07$0.071,000
9/18/2026$0.07$0.07$0.07$0.07$0.073,830
9/16/2026$0.07$0.07$0.07$0.07$0.077,000
9/15/2026$0.07$0.07$0.07$0.07$0.07349,783
9/14/2026$0.07$0.07$0.07$0.07$0.0747,000
9/10/2026$0.07$0.07$0.07$0.07$0.0736,000

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MIR's historical volatility

HistoricalForecast68%95%
C$0.02C$0.07C$0.12C$0.17C$0.22C$0.27TodayApr 23Jul 9Sep 28Nov 10Dec 24Feb 5

30-Day Vol

100.1%

Annualized

90-Day Vol

98.3%

Annualized

Trend (90d)

+31.1%

Annualized drift

90d Mean

C$0.08

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.07C$0.05 – C$0.10
60 trading daysC$0.08C$0.05 – C$0.12
90 trading daysC$0.08C$0.04 – C$0.14

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About MedMira Inc

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Financials

Revenue (TTM)
$370,568
EBITDA
$-1.94M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
0.00
Book Value
-0.04

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About MIR

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
VLIVision Lithium Inc$0.16+1500.00%
ENEVEnerev5 Metals Inc$0.01+100.00%
GRIGalore Resources Inc$0.02+100.00%
MTLOMartello Technologies Group Inc$0.01+100.00%
XTAO-UXTAO Inc.$0.64+39.13%
CELLGrid Battery Metals Inc.$0.02+33.33%
HANSHanstone Gold Corp$0.02+33.33%
DARDarelle Online Solutions Inc$1.00+29.87%

MIR.V news timeline

15 articles covering MIR.V, most recent first

Latest

Why MedMira Inc stock is skyrocketing today

•Stocks

Advertisement